Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group
Authors
Keywords
-
Journal
THORAX
Volume 71, Issue 2, Pages 177-184
Publisher
BMJ
Online
2016-01-15
DOI
10.1136/thoraxjnl-2014-206677
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
- (2014) K. M. Kerr et al. ANNALS OF ONCOLOGY
- Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer
- (2014) P. De Leyn et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Integrating Massively Parallel Sequencing into Diagnostic Workflows and Managing the Annotation and Clinical Interpretation Challenge
- (2014) Karin S. Kassahn et al. HUMAN MUTATION
- A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer
- (2014) Maruja E. Lira et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Multicenter ALK Testing in Non–Small-Cell Lung Cancer: Results of a Round Robin Test
- (2014) Maximilian von Laffert et al. Journal of Thoracic Oncology
- Multicenter Immunohistochemical ALK-Testing of Non–Small-Cell Lung Cancer Shows High Concordance after Harmonization of Techniques and Interpretation Criteria
- (2014) Maximilian von Laffert et al. Journal of Thoracic Oncology
- ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features
- (2014) Yunjian Pan et al. LUNG CANCER
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- The Molecular Detection and Clinical Significance of ALK Rearrangement in Selected Advanced Non-Small Cell Lung Cancer: ALK Expression Provides Insights into ALK Targeted Therapy
- (2014) Ning-Ning Zhang et al. PLoS One
- Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry
- (2014) Esther Conde et al. PLoS One
- O1-132 * CRIZOTINIB TREATMENT IN PATIENTS (PTS) WITH ADVANCED ROS1-REARRANGED NON-SMALL CELL LUNG CANCER (NSCLC)
- (2013) S.- H. I. Ou et al. ANNALS OF ONCOLOGY
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
- (2013) Neal I. Lindeman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Native and rearranged ALK copy number and rearranged cell count in non-small cell lung cancer
- (2013) D. Ross Camidge et al. CANCER
- Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance
- (2013) M Dietel et al. CANCER GENE THERAPY
- Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers
- (2013) E. Conde et al. Clinical & Translational Oncology
- Radical treatment of non-small cell lung cancer during the last 5 years
- (2013) Paula McCloskey et al. EUROPEAN JOURNAL OF CANCER
- Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment
- (2013) Donghui Huang et al. GENOMICS
- Improvement in the quality of molecular analysis ofEGFRin non-small-cell lung cancer detected by three rounds of external quality assessment
- (2013) Zandra C Deans et al. JOURNAL OF CLINICAL PATHOLOGY
- Results of the First Italian External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non–Small-Cell Lung Cancer
- (2013) Nicola Normanno et al. Journal of Thoracic Oncology
- Detection of ALK-Positive Non–Small-Cell Lung Cancers on Cytological Specimens: High Accuracy of Immunocytochemistry with the 5A4 Clone
- (2013) Spasenija Savic et al. Journal of Thoracic Oncology
- Large-Scale Screening and Molecular Characterization of EML4-ALK Fusion Variants in Archival Non–Small-Cell Lung Cancer Tumor Specimens Using Quantitative Reverse Transcription Polymerase Chain Reaction Assays
- (2013) Tianhong Li et al. Journal of Thoracic Oncology
- Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): Results of a multi-centre ALK-testing
- (2013) Maximilian v. Laffert et al. LUNG CANCER
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
- (2013) I A Du Rand et al. THORAX
- Role of Fluorescence in situ Hybridization in Lung Cancer Cytology
- (2012) Spasenija Savic et al. ACTA CYTOLOGICA
- ROS1 Receptor Tyrosine Kinase, a Druggable Target, is Frequently Overexpressed in Non-Small Cell Lung Carcinomas Via Genetic and Epigenetic Mechanisms
- (2012) Hee Jin Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Ancillary techniques on direct-smear aspirate slides
- (2012) Stewart M. Knoepp et al. CANCER CYTOPATHOLOGY
- Intratumor Heterogeneity: Evolution through Space and Time
- (2012) C. Swanton CANCER RESEARCH
- The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5' and 3' Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers
- (2012) R. Wang et al. CLINICAL CANCER RESEARCH
- Identifying and Targeting ROS1 Gene Fusions in Non-Small Cell Lung Cancer
- (2012) K. D. Davies et al. CLINICAL CANCER RESEARCH
- Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections
- (2012) Berit Maria Müller et al. JOURNAL OF CLINICAL PATHOLOGY
- Guideline on the requirements of external quality assessment programs in molecular pathology
- (2012) J. Han van Krieken et al. VIRCHOWS ARCHIV
- EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
- (2012) Erik Thunnissen et al. VIRCHOWS ARCHIV
- CT-Guided Percutaneous Needle Biopsy of the Chest: Preprocedural Evaluation and Technique
- (2011) Carol C. Wu et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial
- (2011) J. Hetzel et al. EUROPEAN RESPIRATORY JOURNAL
- EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy
- (2011) E. Thunnissen et al. JOURNAL OF CLINICAL PATHOLOGY
- Formalin Fixation at Low Temperature Better Preserves Nucleic Acid Integrity
- (2011) Gianni Bussolati et al. PLoS One
- Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer
- (2010) Jouke T. Annema et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Computed Tomography–Guided Percutaneous Needle Biopsy of Pulmonary Nodules: Impact of Nodule Size on Diagnostic Accuracy
- (2009) Nishita Kothary et al. Clinical Lung Cancer
- Emerging ethnic differences in lung cancer therapy
- (2008) I Sekine et al. BRITISH JOURNAL OF CANCER
- Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib
- (2008) Kazuya Taniguchi et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started